MC
MDT icon

Moors & Cabot’s Medtronic MDT Stock Holding History

Moors & Cabot’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$4K – 876
2022
Q1 		$4K Buy
+500
New +$52.8K ﹤0.01% 867
2021
Q1 		– Sell
-1,300
Closed -$3K – 818
2020
Q4 		$3K Sell
1,300
-4,200
-76% -$462K ﹤0.01% 733
2020
Q3 		$12K Buy
5,500
+3,000
+120% +$301K ﹤0.01% 684
2020
Q2 		$1K Buy
+2,500
New +$240K ﹤0.01% 669

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Moors & Cabot's MDT Position: Q2 2026 in Review

Moors & Cabot increased its Medtronic (MDT) stake by 1.6% in Q2 2026, buying an estimated $81.3K and bringing the position to 62,233 shares worth $4.87M. The position accounts for 0.19% of the portfolio, ranked #106.

Moors & Cabot first reported a position in MDT in Q1 2014 and has held it in 50 quarters since. The position peaked at $7.47M in Q1 2022. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Moors & Cabot held 62,233 shares of Medtronic worth $4.87M as of Q2 2026.
  • Moors & Cabot bought 1,008 Medtronic shares in Q2 2026, an estimated $81.3K.
  • Medtronic made up 0.19% of Moors & Cabot's portfolio in Q2 2026, its #106 holding.
  • Moors & Cabot first reported a position in Medtronic in Q1 2014 and has held it in 50 quarters since.
  • Moors & Cabot's Medtronic position peaked at $7.47M in Q1 2022.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.